國立虎尾科技大學 |

Nanovaccines = An Innovative Technology to Fight Human and Animal Diseases /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Nanovaccines/ by Sergio Rosales-Mendoza, Omar González-Ortega.
Reminder of title:	An Innovative Technology to Fight Human and Animal Diseases /
Author:	Rosales-Mendoza, Sergio.
other author:	González-Ortega, Omar.
Description:	X, 343 p. 89 illus., 62 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Biomaterials. -
Online resource:	https://doi.org/10.1007/978-3-030-31668-6
ISBN:	9783030316686

Nanovaccines = An Innovative Technology to Fight Human and Animal Diseases /
Rosales-Mendoza, Sergio.

NanovaccinesAn Innovative Technology to Fight Human and Animal Diseases /[electronic resource] :by Sergio Rosales-Mendoza, Omar González-Ortega. - 1st ed. 2019. - X, 343 p. 89 illus., 62 illus. in color.online resource.

Chapter 1. Nanovaccines and the history of vaccinology -- Chapter 2. The mucosal immune system an outlook for nanovaccines development -- Chapter 3. Gold-based mucosal nanovaccines -- Chapter 4. PLGA-based mucosal nanovaccines -- Chapter 5. Silica-based mucosal nanovaccines -- Chapter 6. Nanogels-based mucosal vaccines -- Chapter 7. Carbon nanotubes-based mucosal vaccines -- Chapter 8. Chitosan-based mucosal nanovaccines -- Chapter 9. Liposomes-based mucosal nanovaccines -- Chapter 10. Virus-like particles-based mucosal nanovaccines -- Chapter 11. Perspectives for field of nanovaccines.

This book provides a compilation of the current developments in mucosal nanovaccines, which are an attractive approach to fight against infectious and non-communicable diseases. Since nanomaterials possess unique properties; many of them have a positive effect on vaccine efficacy when used as antigen carriers and have been applied in vaccinology with significant advances over the past years. This book addresses the methodologies for mucosal nanovaccines synthesis; based on the following nanomaterials: gold, PLGA, silica, and chitosan nanoparticles; as well as nanogels, carbon nanotubes, liposomes, and Virus-like particles. A description of the immunogenic properties of the mucosal nanovaccines is presented, highlighting the improvements achieved with this approach when compared to conventional formulations. Mucosal vaccines constitute the most practical immunization approach since they are easy to administer (promoting patient´s comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae). In this context, the potential of nanovaccines to result in new mucosal formulations in the benefit of global health is analyzed. Covers the synthesis and functionalization of nanomaterials for the development of nanovaccines; Discusses the underlying mechanisms involved in the induction of immune responses through mucosal compartments and the advantages of nanomaterials in the formulation of nanovaccines; Transmits the state of the art for the development of mucosal nanovaccines; Provides routes for the design and evaluation of mucosal nanovaccines; Presents key perspectives for the field of mucosal vaccine development.

ISBN: 9783030316686

Standard No.: 10.1007/978-3-030-31668-6doiSubjects--Topical Terms:

677000
Biomaterials.

LC Class. No.: R857.M3

Dewey Class. No.: 620.11

Nanovaccines = An Innovative Technology to Fight Human and Animal Diseases /
LDR:03844nam a22004095i 4500 001 1011523
003 DE-He213
005 20200702083128.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030316686 $9 978-3-030-31668-6
024 7 $a 10.1007/978-3-030-31668-6 $2 doi
035 $a 978-3-030-31668-6
050 4 $a R857.M3
072 7 $a TGM $2 bicssc
072 7 $a TEC021000 $2 bisacsh
072 7 $a TGM $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 620.11 $2 23
100 1 $a Rosales-Mendoza, Sergio. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1108613
245 1 0 $a Nanovaccines $h [electronic resource] : $b An Innovative Technology to Fight Human and Animal Diseases / $c by Sergio Rosales-Mendoza, Omar González-Ortega.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a X, 343 p. 89 illus., 62 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Nanovaccines and the history of vaccinology -- Chapter 2. The mucosal immune system an outlook for nanovaccines development -- Chapter 3. Gold-based mucosal nanovaccines -- Chapter 4. PLGA-based mucosal nanovaccines -- Chapter 5. Silica-based mucosal nanovaccines -- Chapter 6. Nanogels-based mucosal vaccines -- Chapter 7. Carbon nanotubes-based mucosal vaccines -- Chapter 8. Chitosan-based mucosal nanovaccines -- Chapter 9. Liposomes-based mucosal nanovaccines -- Chapter 10. Virus-like particles-based mucosal nanovaccines -- Chapter 11. Perspectives for field of nanovaccines.
520 $a This book provides a compilation of the current developments in mucosal nanovaccines, which are an attractive approach to fight against infectious and non-communicable diseases. Since nanomaterials possess unique properties; many of them have a positive effect on vaccine efficacy when used as antigen carriers and have been applied in vaccinology with significant advances over the past years. This book addresses the methodologies for mucosal nanovaccines synthesis; based on the following nanomaterials: gold, PLGA, silica, and chitosan nanoparticles; as well as nanogels, carbon nanotubes, liposomes, and Virus-like particles. A description of the immunogenic properties of the mucosal nanovaccines is presented, highlighting the improvements achieved with this approach when compared to conventional formulations. Mucosal vaccines constitute the most practical immunization approach since they are easy to administer (promoting patient´s comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae). In this context, the potential of nanovaccines to result in new mucosal formulations in the benefit of global health is analyzed. Covers the synthesis and functionalization of nanomaterials for the development of nanovaccines; Discusses the underlying mechanisms involved in the induction of immune responses through mucosal compartments and the advantages of nanomaterials in the formulation of nanovaccines; Transmits the state of the art for the development of mucosal nanovaccines; Provides routes for the design and evaluation of mucosal nanovaccines; Presents key perspectives for the field of mucosal vaccine development.
650 0 $a Biomaterials. $3 677000
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Vaccines. $3 582184
650 0 $a Nanotechnology. $3 557660
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Vaccine. $3 782685
700 1 $a González-Ortega, Omar. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1305717
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030316679
776 0 8 $i Printed edition: $z 9783030316693
776 0 8 $i Printed edition: $z 9783030316709
856 4 0 $u https://doi.org/10.1007/978-3-030-31668-6
912 $a ZDB-2-CMS
912 $a ZDB-2-SXC
950 $a Chemistry and Materials Science (SpringerNature-11644)
950 $a Chemistry and Material Science (R0) (SpringerNature-43709)